Effects of microRNA-424-5p on proliferation, migration and invasion of colorectal cancer cells by regulating OTX1

doi:10.3760/cma.j.issn.1673-422X.2019.06.001

Abstract

Abstract: Objective To investigate the correlation of the expression of microRNA-424-5p (miR-424-5p) and orthodenticle homeobox 1 (OTX1) gene in colorectal cancer (CRC) tissue, and the effects of miR-424-5p on the proliferation, migration and invasion of CRC cells HCT116. Methods A total of 60 patients with CRC were collected from June 2017 to June 2018 in Department of Colorectal Surgery of Third Affiliated Hospital of Kunming Medical University. Real time quantitative PCR (RTqPCR) was used to detect the expression of miR-424-5p and OTX1 mRNA in 60 cases of CRC tissues, paracarcinoma tissues and CRC cell lines. The correlation between the expression of miR-424-5p and OTX1 gene was further analyzed. miR-NC (miR-NC group) and miR-424-5p-mimic (miR-424-5pmimic group) were transfected into HCT116 cells. CCK-8 assay, scratch assay and Transwell assay were used to detect the effects of miR-424-5p on the proliferation, migration and invasion of HCT116 cells. The effect of miR-424-5p on the expression of OTX1 protein was detected by Western blotting. The luciferase report assay was used to detect the influence of miR-424-5p on the luciferase activity of OTX1-3′UTR vector. ResultsThe relative expressions of OTX1 mRNA in CRC tissues and paracarcinoma tissues were 1.049±0.446 and 0.639±0.178 (t=－6.583, P<0.001); and the relative expression of miR-424-5p in CRC tissues and para-carcinoma tissues were 0.865±0.261 and 1.329±0.387 (t=7.705, P<0.001), with statistically significant differences. Negative correlation was found between the expression of miR-424-5p and OTX1 mRNA in CRC tissues (r=－0.439, P=0.015). The absorbance values of HCT116 cells transfected with miR-424-5pmimic were 0.813±0.064, 0.960±0.098, 1.287±0.192 on 72, 96 and 120 hours respectively, and those of HCT116 cells transfected with miR-NC were 1.163±0.158, 1.645±0.117 and 2.043±0.236. The proliferation ability of miR-424-5pmimic group was lower than that of miR-NC group and the differences between the two groups were statistically significant (t=3.538, P=0.024; t=7.778, P=0.001; t=4.257, P=0.013). The scratch assay showed that the migration of HCT116 cells in miR-424-5pmimic group was inhibited as compared with miR-NC group. The numbers of cells permeating septum of miR-NC and miR-424-5pmimic group were 177.104±17.834 and 35.667±13.634, and the difference was statistically significant (t=15.246, P<0.001). The relative expressions of OTX1 protein in miR-NC and miR-424-5p-mimic group were 0.862±0.121 and 0.342±0.103 respectively, and the difference was statistically significant (t＝16.286, P<0.001). Luciferase report assay showed that the luciferase activities of wt-OTX1-3′UTR and mut-OTX1-3′UTR vector were 0.305±0.095 and 0.898±0.080 after over expression of miR-424-5p, and the difference was statistically significant (P<0.001). Conclusion The expressions of miR-424-5p and OTX1 mRNA are negatively correlated in CRC tissue. miR-424-5p can inhibit the proliferation, migration and invasion of CRC cells by down-regulating the expression of OTX1.

Key words: Colorectal neoplasms, MicroRNAs, Cell proliferation, OTX1

Yu Kun, Wang Weiya, Cai Xinyi, Cheng Xianshuo, Zhao Xiaofeng, Bie Yaqin, Li Qiang. Effects of microRNA-424-5p on proliferation, migration and invasion of colorectal cancer cells by regulating OTX1[J]. Journal of International Oncology, 2019, 46(6): 321-326.

References

［1］ Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492. ［2］ Wang F, Wang J, Yang X, et al. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT［J］. Diagn Pathol, 2016, 11(1): 88. DOI: 10.1186/s13000-016-0536-9. ［3］ Zhang M, Zeng J, Zhao Z, et al. Loss of miR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in nonsmall cell lung cancer［J］. Mol Carcinog, 2017, 56(3): 821-832. DOI: 10.1002/mc.22536. ［4］ Pantò MR, Zappalà A, Tuorto F, et al. Role of the Otx1 gene in cell differentiation of mammalian cortex［J］. Eur J Neurosci, 2004, 19(10): 2893-2902. DOI: 10.1111/j.0953-816X.2004.03326.x. ［5］ de Haas T, Oussoren E, Grajkowska W, et al. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas［J］. J Neuropathol Exp Neurol, 2006, 65(2): 176-186. DOI: 10.1097/01.jnen.0000199576.70923.8a. ［6］ Terrinoni A, Pagani IS, Zucchi I, et al. OTX1 expression in breast cancer is regulated by p53［J］. Oncogene, 2011, 30(27): 3096-3103. DOI: 10.1038/onc.2011.31. ［7］ Yu K, Cai XY, Li Q, et al. OTX1 promotes colorectal cancer progression through epithelialmesenchymal transition［J］. Biochem Biophys Res Commun, 2014, 444(1): 1-5. DOI: 10.1016/j.bbrc.2013.12.125. ［8］ Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance［J］. Cancer Lett, 2018, 438: 126-132. DOI: 10.1016/j.canlet.2018.09.019. ［9］ Zhang Y, Li T, Guo P, et al. MiR-4245p reversed epithelialmesenchymal transition of anchorageindependent HCC cells by directly targeting ICAT and suppressed HCC progression［J］. Sci Rep, 2014, 4: 6248. DOI: 10.1038/srep06248. ［10］ Wu CT, Lin WY, Chang YH, et al. DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer［J］. Oncotarget, 2015, 6(27): 24119-24131. DOI: 10.18632/oncotarget.4431. ［11］ Jepsen RK, Novotny GW, Klarskov LL, et al. Intratumor heterogeneity of microRNA-92a, microRNA-375 and microRNA-424 in colorectal cancer［J］. Exp Mol Pathol, 2016, 100(1): 125-131. DOI: 10.1016/j.yexmp.2015.12.004. ［12］ Yang H, Zheng W, Shuai X, et al. MicroRNA424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma［J］. Oncotarget, 2015, 6(29): 27736-27750. DOI: 10.18632/oncotarget.4811. ［13］ Chen B, Duan L, Yin G, et al. Simultaneously expressed miR424 and miR381 synergistically suppress the proliferation and survival of renal cancer cells—Cdc2 activity is upregulated by targeting WEE1［J］. Clinics (Sao Paulo), 2013, 68(6): 825-833. DOI: 10.6061/clinics/2013(06)17. ［14］ Peng HY, Jiang SS, Hsiao JR, et al. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma ［J］. Mol Oncol, 2016, 10(6): 895-909. DOI: 10.1016/j.molonc.2016.03.001. ［15］ Wei S, Li Q, Li Z, et al. miR4245p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway［J］. Oncotarget, 2016, 7(46): 75185-75196. DOI: 10.18632/oncotarget.12092. ［16］ Long XH, Mao JH, Peng AF, et al. Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase［J］. Exp Ther Med, 2013, 5(4): 1048-1052. DOI: 10.3892/etm.2013.959. ［17］ Zhang D, Shi Z, Li M, et al. Hypoxiainduced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis［J］. Cell Death Dis, 2014, 5: e1301. DOI: 10.1038/cddis.2014.240. ［18］ Qin SC, Zhao Z, Sheng JX, et al. Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion［J］. Oncol Rep, 2018, 40(4): 1907-1916. DOI: 10.3892/or.2018.6596.

[1]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[2]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[3]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[4]	Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan. Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity， proliferation， and apoptosis of multiple myeloma cells [J]. Journal of International Oncology, 2024, 51(3): 129-136.
[5]	Gong Yan, Chen Honglei. Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer [J]. Journal of International Oncology, 2024, 51(3): 186-190.
[6]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118.
[7]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519.
[8]	Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong. Expression and clinical significance of ASB6 in colorectal cancer tissues [J]. Journal of International Oncology, 2023, 50(8): 470-474.
[9]	Chen Zhuo, Tao Jun, Chen Lin, Ke Jing. Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer [J]. Journal of International Oncology, 2023, 50(5): 268-273.
[10]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin. lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway [J]. Journal of International Oncology, 2023, 50(4): 202-207.
[11]	Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun. Construction of postoperative prognosis model for patients with colorectal cancer [J]. Journal of International Oncology, 2023, 50(3): 157-163.
[12]	Xu Liangfu, Li Yuanfei. Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer [J]. Journal of International Oncology, 2023, 50(3): 186-190.
[13]	Liu Yujie, Zhao Zhiqiang, Wang Zicheng. Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer [J]. Journal of International Oncology, 2023, 50(12): 717-722.
[14]	Tao Hong, Yin Hong, Luo Hong, Tao Jiayu. Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer [J]. Journal of International Oncology, 2023, 50(11): 683-687.
[15]	Wang Xi, Wu Chuanqing. Research progress in reversing multidrug resistance in colorectal cancer [J]. Journal of International Oncology, 2023, 50(1): 42-46.